CN109602022A - A kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection - Google Patents
A kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection Download PDFInfo
- Publication number
- CN109602022A CN109602022A CN201811548951.7A CN201811548951A CN109602022A CN 109602022 A CN109602022 A CN 109602022A CN 201811548951 A CN201811548951 A CN 201811548951A CN 109602022 A CN109602022 A CN 109602022A
- Authority
- CN
- China
- Prior art keywords
- oyster
- hpv virus
- preventing tumor
- virus infection
- peptide formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 45
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 16
- 238000009472 formulation Methods 0.000 title claims abstract description 14
- 239000000203 mixture Substances 0.000 title claims abstract description 14
- 230000009385 viral infection Effects 0.000 title claims abstract description 14
- 235000020636 oyster Nutrition 0.000 claims abstract description 64
- 241000237502 Ostreidae Species 0.000 claims abstract description 54
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 22
- 239000000463 material Substances 0.000 claims abstract description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 8
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims abstract description 8
- 229960004494 calcium gluconate Drugs 0.000 claims abstract description 8
- 239000004227 calcium gluconate Substances 0.000 claims abstract description 8
- 235000013927 calcium gluconate Nutrition 0.000 claims abstract description 8
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 8
- 239000011669 selenium Substances 0.000 claims abstract description 8
- 235000011478 zinc gluconate Nutrition 0.000 claims abstract description 8
- 239000011670 zinc gluconate Substances 0.000 claims abstract description 8
- 229960000306 zinc gluconate Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 230000015556 catabolic process Effects 0.000 claims description 5
- 238000006731 degradation reaction Methods 0.000 claims description 5
- 238000002360 preparation method Methods 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 239000008158 vegetable oil Substances 0.000 claims description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 4
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 4
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 4
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 4
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 4
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 4
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 239000004375 Dextrin Substances 0.000 claims description 3
- 229920001353 Dextrin Polymers 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 235000019425 dextrin Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 239000006188 syrup Substances 0.000 claims description 3
- 235000020357 syrup Nutrition 0.000 claims description 3
- 241000700605 Viruses Species 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 102000005606 Activins Human genes 0.000 abstract description 2
- 108010059616 Activins Proteins 0.000 abstract description 2
- 238000010521 absorption reaction Methods 0.000 abstract description 2
- 239000000488 activin Substances 0.000 abstract description 2
- 230000000840 anti-viral effect Effects 0.000 abstract description 2
- 230000007233 immunological mechanism Effects 0.000 abstract description 2
- 210000004777 protein coat Anatomy 0.000 abstract description 2
- 230000001173 tumoral effect Effects 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000036039 immunity Effects 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 150000003384 small molecules Chemical class 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000024035 chronic otitis media Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005495 thyroid hormone Substances 0.000 description 1
- 229940036555 thyroid hormone Drugs 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection, it includes following raw material: oyster small-molecular peptides 45-50%, yeast selenium 3-5%, zinc gluconate 5-8%, calcium gluconate 5-8%, auxiliary material 29-42%；The present invention it is not only orally available but also can external application, the protein coat of oyster small-molecular peptides can neutralize mutually with hpv virus coat positive and negative charge, destroy hpv virus；Oyster small-molecular peptides can also human activin immunologic mechanism, inhibit virocyte；Yeast selenium is added and further increases pre- preventing tumor and antiviral effect；Zinc gluconate, calcium gluconate is added, effectively improves the absorption of albumen peptide formulations, improves the effect of pre- preventing tumor and anti-hpv virus infection.
Description
Technical field
The present invention relates to substance separation and extraction technology fields, and in particular to one kind has pre- preventing tumor and anti-hpv virus sense
The albumen peptide formulations of dye.
Background technique
Peptide is the compound segment between amino acid and protein, passes through peptide by 2 or 2 or more amino acid moleculars
Key is connected with each other, and is the structure and function fragment of protein, many active materials in body, such as hormone, enzyme essence
On be all peptide, peptide has strong biological activity, wherein it is active by force to surely belong to small-molecular peptides form with 2-6 amino acid.
Protein peptides not only have a variety of body metabolisms and physiological regulation function, moreover it is possible to provide nutrition for body, have antibacterial,
Antiviral, lowering blood pressure and blood fat increases the physiological functions such as immunity, and edible safety is high, is that current food science and technology is most popular
Research topic and great development prospect function factor.
Oyster also cries oyster or oyster, is seashell, in subtropical zone, the cultivation of the coastal all suitable oyster in the torrid zone, China point
Cloth is very wide, and North gets the Yalu River, south is coastal all to produce oyster to Hainan Island.Oyster is mollusk, there are two shell, it is one small and
Flat, another is big and swells, the surface irregularity of shell.Meat is edible, and can obtain through refining oyster sauce, meat, shell, and oil can all be used as medicine.
Recent studies shows: oyster is containing 18 kinds of amino acid, liver glycogen, B family vitamin, taurine and calcium, phosphorus, iron, zinc etc.
Nutritional ingredient often eats and immunity of organisms can be improved, and contained taurine can reducing blood lipid, blood pressure lowering.Clinically, oyster is being treated
Insomnia, chronic otitis media, children's ephidrosis, fibroid and infantile enuresis etc. have curative effect outstanding.Oyster is extracted
Object has antibacterial action, has inhibiting effect to poliovirus and influenza virus, water soluble ingredient still improves animal machine
Body immunity etc..
Oyster peptide is that the protein extracted from oyster digested tankage is raw material, separates skill using orientation digestion and specific small peptide
The small molecule oligopeptide that art obtains.
Oyster peptide have enhancing male's sexual, protection liver, strengthen immunity, it is hypoglycemic, prevention cardiovascular and cerebrovascular disease,
Antitumor action.The effect of how further increasing oyster peptide product becomes a problem.
Summary of the invention
In view of the defects and deficiencies of the prior art, the present invention intends to provide one kind to have pre- preventing tumor and anti-hpv
The albumen peptide formulations of virus infection.
To achieve the above object, the technical solution adopted by the present invention is that: it include following raw material: oyster small molecule
Peptide 45-50%, yeast selenium 3-5%, zinc gluconate 5-8%, calcium gluconate 5-8%, auxiliary material 29-42%；
Further, the auxiliary material includes microcrystalline cellulose, sucrose, hydroxypropyl methylcellulose；
Further, the accessory package contains dextrin, lactose, mannitol, syrup；
Further, the preparation method of oyster small-molecular peptides comprises the following steps:
One, oyster is put into clear water, 2% salt and 0.5-1% vegetable oil into clear water, impregnates 2 hours and take out, then clearly
Water is cleaned and takes oyster software；
Two, oyster software crushed, ungrease treatment, form oyster liquid, and adjust the PH of oyster liquid；
Three, protease is added in oyster liquid and carries out enzyme degradation treatment；
Four, after digesting, destroy the enzyme treatment is carried out, obtains oyster small-molecular peptides.
After adopting the above scheme, a kind of protein peptides system with pre- preventing tumor and anti-hpv virus infection of the present invention
Agent has the advantage that
1, the protein coat of oyster small-molecular peptides can neutralize mutually with hpv virus coat positive and negative charge, destroy hpv virus；
2, oyster small-molecular peptides can also human activin immunologic mechanism, inhibit virocyte；
3, yeast selenium is added, have it is anti-oxidant, adjust thyroid hormone, control virus to disease cause mutation, antitumor
Effect；
4, zinc gluconate, calcium gluconate is added, effectively improves the absorption of albumen peptide formulations, improve pre- preventing tumor and resists
The effect of hpv virus infection；
5, not only orally available but can external application, it is widely used.
Specific embodiment
The present invention is further illustrated below.
Embodiment one: a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection, it includes following parts by weight
Raw material: oyster small-molecular peptides 45%, yeast selenium 3%, zinc gluconate 6%, calcium gluconate 6%, auxiliary material 40%；Described is auxiliary
Material includes microcrystalline cellulose, sucrose, hydroxypropyl methylcellulose；
Wherein: the preparation method of oyster small-molecular peptides comprises the following steps:
One, oyster is put into clear water, 2% salt and 0.5-1% vegetable oil into clear water, impregnates 2 hours and take out, then clearly
Water is cleaned and takes oyster software；
Two, oyster software crushed, ungrease treatment, form oyster liquid, and adjust the PH of oyster liquid；
Three, protease is added in oyster liquid and carries out enzyme degradation treatment；
Four, after digesting, destroy the enzyme treatment is carried out, obtains oyster small-molecular peptides.
Embodiment two: a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection, it includes following parts by weight
Raw material: oyster small-molecular peptides 50%, yeast selenium 5%, zinc gluconate 8%, calcium gluconate 8%, auxiliary material 29%；Described is auxiliary
Material includes dextrin, lactose, mannitol, syrup；
Wherein: the preparation method of oyster small-molecular peptides comprises the following steps:
One, oyster is put into clear water, 2% salt and 0.5-1% vegetable oil into clear water, impregnates 2 hours and take out, then clearly
Water is cleaned and takes oyster software；
Two, oyster software crushed, ungrease treatment, form oyster liquid, and adjust the PH of oyster liquid；
Three, protease is added in oyster liquid and carries out enzyme degradation treatment；
Four, after digesting, destroy the enzyme treatment is carried out, obtains oyster small-molecular peptides.
Embodiment three: a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection, it includes following parts by weight
Raw material: oyster small-molecular peptides 48%, yeast selenium 3%, zinc gluconate 5%, calcium gluconate 5%, auxiliary material 39%；Described is auxiliary
Material includes microcrystalline cellulose, sucrose, hydroxypropyl methylcellulose；
Wherein: the preparation method of oyster small-molecular peptides comprises the following steps:
One, oyster is put into clear water, 2% salt and 0.5-1% vegetable oil into clear water, impregnates 2 hours and take out, then clearly
Water is cleaned and takes oyster software；
Two, oyster software crushed, ungrease treatment, form oyster liquid, and adjust the PH of oyster liquid；
Three, protease is added in oyster liquid and carries out enzyme degradation treatment；
Four, after digesting, destroy the enzyme treatment is carried out, obtains oyster small-molecular peptides.
The above is merely illustrative of the technical solution of the present invention, rather than limits those of ordinary skill in the art to this hair
The other modifications or equivalent replacement that bright technical solution is made, as long as it does not depart from the spirit and scope of the technical scheme of the present invention,
It is intended to be within the scope of the claims of the invention.
Claims (4)
1. a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection, it is characterised in that it includes following parts by weight
Raw material: oyster small-molecular peptides 45-50%, yeast selenium 3-5%, zinc gluconate 5-8%, calcium gluconate 5-8%, auxiliary material 29-
42%.
2. a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection according to claim 1, feature exist
Include microcrystalline cellulose, sucrose, hydroxypropyl methylcellulose in the auxiliary material.
3. a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection according to claim 1, feature exist
Contain dextrin, lactose, mannitol, syrup in the accessory package.
4. a kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection according to claim 1 or 2 or 3,
It is characterized in that the preparation method of oyster small-molecular peptides comprises the following steps:
One, oyster is put into clear water, 2% salt and 0.5-1% vegetable oil into clear water, impregnates 2 hours and take out, then clear water is washed
Only oyster software is taken；
Two, oyster software crushed, ungrease treatment, form oyster liquid, and adjust the PH of oyster liquid；
Three, protease is added in oyster liquid and carries out enzyme degradation treatment；
Four, after digesting, destroy the enzyme treatment is carried out, obtains oyster small-molecular peptides.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811548951.7A CN109602022A (en) | 2018-12-18 | 2018-12-18 | A kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811548951.7A CN109602022A (en) | 2018-12-18 | 2018-12-18 | A kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109602022A true CN109602022A (en) | 2019-04-12 |
Family
ID=66010618
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811548951.7A Pending CN109602022A (en) | 2018-12-18 | 2018-12-18 | A kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109602022A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1768765A (en) * | 2005-10-28 | 2006-05-10 | 大连水产学院 | Method for preparing antioxidation health-caring oyster product |
| CN105211857A (en) * | 2015-09-30 | 2016-01-06 | 广州金酮医疗科技有限公司 | A kind of alimentation composition and uses thereof |
| CN105412911A (en) * | 2015-12-03 | 2016-03-23 | 天津禹王生物医药科技有限公司 | Oyster peptide beverage |
-
2018
- 2018-12-18 CN CN201811548951.7A patent/CN109602022A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1768765A (en) * | 2005-10-28 | 2006-05-10 | 大连水产学院 | Method for preparing antioxidation health-caring oyster product |
| CN105211857A (en) * | 2015-09-30 | 2016-01-06 | 广州金酮医疗科技有限公司 | A kind of alimentation composition and uses thereof |
| CN105412911A (en) * | 2015-12-03 | 2016-03-23 | 天津禹王生物医药科技有限公司 | Oyster peptide beverage |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106282287B (en) | Method for extracting bioactive polypeptide of ginkgo | |
| TWI516280B (en) | Use of chenopodium formosanum extract for manufacture of composition for enhancing secretion of collagen and preventing cutaneous aging | |
| GB2605893A (en) | Active polysaccharide compound nutrient capable of enhancing immunity and resisting fatigue and preparation method therefor | |
| CN111685286B (en) | Oyster peptide with blood lipid reducing function and preparation method and application thereof | |
| JP5154964B2 (en) | Contains royal jelly-degrading enzyme | |
| CN106819356A (en) | A kind of plateau quinoa peptide and preparation method thereof and medicine-food two-purpose product | |
| CN106359839A (en) | Extraction method of oyster peptides | |
| CN109777849A (en) | A kind of de- bitter peach kernel extracts the preparation method of proteolysis polypeptide | |
| CN109504732A (en) | A kind of preparation method of oyster active peptides | |
| CN1985852A (en) | Process of extracting sea cucumber polyose and other active components from boiled sea cucumber juice | |
| CN1586312A (en) | Method for producing oyster biological active substance and its product | |
| CN110656151A (en) | Method for improving kidney-tonifying and yang-strengthening effects of sea cucumber | |
| CN105380261B (en) | A kind of liver protecting formula food and preparation method thereof containing oligopeptides | |
| CN108634296A (en) | A kind of snowy peak Gallus domesticlus brisson peptide nutrient powder and preparation method thereof | |
| CN1067226C (en) | Soybean peptide ammino acid oral liquid and its prepn | |
| CN105907826B (en) | Clean preparation method of plant polypeptide/protein | |
| CN113512108A (en) | Marine fish skin collagen oligopeptide and preparation method and application thereof | |
| CN110477368B (en) | High-activity cordyceps sinensis powder and preparation method and application thereof | |
| CN1748714A (en) | Method for preparing biological active substance of siphon-worm and its products | |
| CN109602022A (en) | A kind of albumen peptide formulations with pre- preventing tumor and anti-hpv virus infection | |
| CN103652513B (en) | Method for obtaining hypoallergenic entire peanut kernel through biological enzyme preparation treatment | |
| CN104686768A (en) | Sea cucumber compressed tablet candy capable of enhancing immunity with high efficiency | |
| CN102732591A (en) | Preparation method of soybean whey polypeptides with liver protection and antioxidation effects | |
| CN105018557A (en) | Preparation method of pumpkin seed meal small peptides | |
| CN108486201B (en) | Method for extracting bioactive polypeptide of ginkgo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190412 |
|
| RJ01 | Rejection of invention patent application after publication |